key: cord-0735233-5jhx2saf authors: Xie, Wen; Chen, Zhihai; Wang, Qi; Song, Meihua; Cao, Ying; Wang, Lin; Pan, Calvin Q. title: Infection and disease spectrum in individuals with household exposure to SARS‐CoV‐2: A family cluster cohort study date: 2021-02-12 journal: J Med Virol DOI: 10.1002/jmv.26847 sha: 16cfe7dec6816d544f4c3abb6d4a376193553485 doc_id: 735233 cord_uid: 5jhx2saf We primarily quantified exposure patterns, transmission characteristics, and the clinical spectrum of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection among household contacts of individuals with severe coronavirus disease‐2019 (COVID‐19). We conducted a retrospective cohort study of 20 index patients hospitalized with severe COVID‐19 and 79 of their household contacts. We determined the transmission frequency, range of manifestations of SARS‐CoV‐2 infection, and factors associated with infection in household settings. Of the 79 household contacts, 53 (67%) developed SARS‐CoV‐2 infection (49 [62%] symptomatic, 4 [5%] asymptomatic). Eight patients (10%) developed severe COVID‐19, and one died of COVID‐19 pneumonia (case‐fatality rate: 1.9%). The probability of SARS‐CoV‐2 infection was similar in children and adults (55% vs. 72%, p = .14), with children being less likely to develop the symptomatic disease (46% vs. 68%, p = .06). Handwashing ≥ 5 times/day was associated with reduced infection risk (52.8% vs. 76.9%, p = .04). SARS‐CoV‐2 has a high frequency of transmission among household contacts. Nonhospitalized individuals with SARS‐CoV‐2 infection should be quarantined in patient care facilities rather than at home to minimize spread, if possible, and frequent handwashing should be practiced to prevent transmission. respiratory syndrome (MERS) are unavailable in China. Nevertheless, the case R0 of less than 1 and fatality of 34.4% among patients with MERS have been reported by a study in another country. 7 Recent advances have been made in identifying the clinical features, diagnostic methods, and treatment strategies of individuals with COVID- 19 . 3, [8] [9] [10] However, current published studies focus mainly on diagnosed cases that represent only a fraction of all those infected. 3, [8] [9] [10] [11] [12] Many cases of SARS-CoV-2 infection may be missed if contact tracing and testing protocol have not been implemented, especially in the cases of asymptomatic infection without the progress to overt COVID-19. 13 within household. [17] [18] [19] There is no commonly agreed approach regarding quarantine policies for individuals with asymptomatic or mild SARS-CoV-2 infection. We conducted a household study to investigate the epidemiological characteristics and range of clinical manifestations after SARS-CoV-2 exposure. The primary objective was to quantify exposure patterns, transmission characteristics, and the clinical spectrum of SARS-CoV-2 infection. Household contact is the major source of SARS-CoV-2 infection, which particularly puts children at risk. 12 Children have a very different subset of illness, who may develop an exaggerated immune response, characterized by exaggerated cytokine release and manifests with features similar to Kawasaki disease. The syndrome has been referred to as multisystem inflammatory syndrome in children with negative clinical outcomes. 19 We further investigated the characteristics and outcomes of children with COVID-19. We conducted a single-center cohort study on the household contacts of individuals with COVID-19. Patients were recruited from Beijing Ditan Hospital, which is affiliated with the Capital Medical University, an academic tertiary care center in Beijing, China, designated for the diagnosis and treatment of COVID-19. The standard of care for patients with SARS-CoV-2 is described in Section S1. Eligible patients were those who presented to our medical center and also had at least one family member with a confirmed diagnosis of COVID-19. The date range of admission/hospitalization was between January 21 and February 14 in 2020. Epidemiological and clinical data were collected, including data for transmission tree analysis with the chronology of symptom onset and virus transmission recorded; the history of the first presentation and disease progression; and physical findings, laboratory testing results, imaging results, treatment, and outcomes. The requirement for informed consent was waived because the study was retrospective and posed minimal risk to the individuals included in the analysis. Data were collected from medical records and self-reported data from a questionnaire administered during the patient's visit to the clinic or their hospital stay. A sample of the questionnaire is presented in Section S2. Details of the laboratory procedures, sample collection, and testing are also described in Section S3. All computed tomography (CT) findings were confirmed by the chief of the radiology department. The records to obtain the data used in this study were accessed on March 30. Primary measurements included aggregated case counts on outcomes to the proportion of patients with SARS-CoV-2 infection, proportion of patients with COVID-19, proportion of patients with severe COVID-19, and case-fatality rates among household members. The proportion of household members who tested positive for SARS-CoV-2 and the proportion who developed COVID-19 were measured to determine the frequency of SARS-CoV-2 infection and symptomatic disease, respectively. The proportion of household contacts that developed severe COVID-19 and the case-fatality rate, which was defined as the percentage of those with SARS-CoV-2 infection who died due to COVID-19, were also measured. In our study, the index case in the household referred to the first person in the household with a confirmed COVID-19 or positive COVID-19 PCR test without clinical confirmation yet. Other household members were defined as successive (secondary) cases with exposure and their data were included in a separate dataset. Case confirmation for SARS-CoV-2 infection was based on laboratory microbiological diagnosis through detection of the virus using reverse transcription polymerase chain reaction (RT-PCR) assays, regardless of the presence of clinical signs and symptoms. Samples were obtained for RT-PCR testing at the first clinic visit or on the day of admission to the hospital. Those with negative RT-PCR results, who were clinically suspected to be infected, were admitted to a single-occupancy isolation room for further observation until they met the discharge criteria. Successive patients with SARS-CoV-2 infection were assigned further into the subgroups of asymptomatic, mild/moderate COVID-19, and severe COVID-19. Patients who met any of the following criteria were considered as having severe COVID-19: (1) dyspnea with a respiratory rate more than 30/min; (2) hypoxemia with oxygen saturation less than 93%; (3) PaO 2 / FiO 2 less than 300 mmHg; or (4) complications including sepsis, metabolic acidosis, organ failure, or acute respiratory distress syndrome. Noninfected family members were those who had negative RT-PCR test results on at least two samples collected on separate dates and no clinical evidence of COVID-19. Household contacts who did not meet any of these definitions were classified as possible cases. The study protocol was approved by the Institutional Review Board of Beijing Ditan Hospital, Capital Medical University in Beijing (approval number: 2020-015-01). Data were collected from medical records. All data were deidentified before analysis. The need for informed consent was waived by the Institutional Review Board because the study posed minimal risk to the enrollees. Transmission trees were constructed that allowed for the tabulation of exposure frequency and the numbers of successive cases with generations of infection from the index case. Using data from each individual, aggregated case counts of varying disease severity were analyzed and reported as the percentage of participants in each outcome category. χ 2 or Fisher's exact tests were used to identify risk factors for severe COVID-19. Variables with p < .05 in the univariate analyses were further investigated in a multivariate logistic regression model. All statistical analyses were performed using SPSS Version 16.0 (SPSS Inc.). All tests were two-tailed, and p values of less than .05 were considered statistically significant. The index cases had a reported date of symptom onset between January 21, 2020 and February 14, 2020. All individuals in the household were (49/79), and 10% (8/79), respectively. Among the household contacts, the F I G U R E 1 Study subjects and their status of SARS-CoV-2 infection with disease ranges. *These family members were classified as possible infected cases because two had one day of fever (<37.5°C and one had diarrhea (6-7 loose stool/day for 2 days) after contacting the index patients. The community health providers considered that they were unlikely infected and advised patients to be quarantined at home for 14 days. Thus, clinical workup or laboratory investigations were not conducted at the onset of their symptoms, although two of them had two consecutive negative RT-PCR results on throat swab samples after the quarantine period. There were no new infected patients reported to be linked to these family members. There were 69 patients of COVID-19 in our cohort, including 20 index patients and 49 subsequent infected patients in 20 family clusters. These patients were confirmed with the diagnosis between January 21 and February 14 in 2020. During this period, 365 new patients were confirmed with COVID-19 in Beijing City. Thus, our infected patients represented 19% of all cases in the city. The daily reports of cases with confirmed COIVD-19 in Beijing can be found on the website: (https://ncov.dxy.cn/ncovh5/view/pneumonia_area?aid=110000&from=dxy&link=&share=&sourc). incidence of asymptomatic infection was 5% (4/79), and the case-fatality rate among secondary cases was 1.9% (1/53). To investigate the predictors of SARS-CoV-2 infection, we compared epidemiologic features between the noninfected participants and participants with first-generation infection ( Table 2 ). The analyses showed that a significantly higher proportion of those who did not develop infection washed their hands more than five times per day (77% [20/26] Among the 73 participants with laboratory-confirmed COVID-19, including the 20 index cases and 53 secondary cases, six who had transient mild symptoms or asymptomatic infection underwent monitoring for the development of COVID-19 (thus, some variables were not recorded). The clinical data of the 73 case patients are shown in Table 3 . Their mean age was 42 years and 43% were male. Common initial symptoms included fever (80%), cough (56%), and fatigue (44%), and myalgia/arthralgia (25%), whereas diarrhea (8%) or nausea/vomiting (1%) occurred infrequently. Common initial findings were as follows: lymphopenia (63%), Compared to the nonsevere cases, patients with severe COVID-19 were significantly older and were more likely to have a history of smoking or pre-existing chronic conditions. Severe cases were significantly more common among men than women. Characteristics of severe COVID-19 included fever (temperature ≥ 38°C), shortness of breath, oxygen saturation less than 93%, lower (Table 3) . However, there was no significant difference in the mean duration from symptom onset to recovery between children and adults (19.1 ± 5.6 days vs 11.8 ± 6.5 days; p = .75). Abbreviations: IQR, interquartile rangel; RT-PCR, reverse transcription polymerase chain reaction. a Participants in this group comprised individuals with no change in health and negative RT-PCR results on at least two samples collected on different days (confirmed noninfected), and possible cases but unlikely to be infected (clinically well and RT-PCR negative at the end of the quarantine period). b Index patients were excluded from this group. XIE ET AL. .01 . case-fatality rate since we studied all cases of infection and followed them until their recovery or death. Patients with asymptomatic infection remain a major concern regarding SARS-CoV-2 transmission. Many published studies have presented the epidemiologic and clinical features of patients with COVID-19 admitted to hospitals. 3, [8] [9] [10] [11] [12] However, these cohorts only investigated the pathogenicity of SARS-CoV-2 and the case-fatality rates of COVID-19. The asymptomatic SARS-CoV-2 infection was first largely reported on the Diamond Princess Cruise ship, where an estimated 17.9% of cases were asymptomatic on the board. 25 Buitrago-Garcia et al. 26 and how to complete the quarantine period. In our study, since our focus was on the transmission of the family cluster, our data reflects the local practice patterns on contract tracing among the transmission within the household and family members, which did not include all encounters of the index cases. 13 In the clinical data analyses, we identified the following independent predictors for developing severe COVID-19: shortness of breath as an initial symptom, pre-existing chronic conditions, and a his- The data that support the findings of this study are available from the corresponding author on reasonable request. Participant data without names and identifiers may be shared with other researchers XIE ET AL. after approval from the corresponding author and the authorities, including the Institutional Review Board and the National Health Commission. A proposal with a detailed description of study objectives and a statistical analysis plan will be needed for evaluation of the reasonability to request for our data. The corresponding author will make a decision based on these materials. The study protocol was approved by the Institutional Review Board of Beijing Ditan Hospital, Capital Medical University in Beijing (approval number: 2020-015-01). The requirement for informed consent was waived because the study was retrospective and posed minimal risk to the individuals included in the analysis. The requirement for informed consent was waived because the study was retrospective and had minimal risk. http://orcid.org/0000-0001-6481-4781 Calvin Q. Pan https://orcid.org/0000-0002-3723-6688 A novel coronavirus from patients with pneumonia in China Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Clinical characteristics of coronavirus disease 2019 in China Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases Transmission of MERScoronavirus in household contacts Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia First case of 2019 novel coronavirus in the United States Novel coronavirus infection in hospitalized infants under 1 year of age in China Preventive and treatment strategies of COVID-19: From community to clinical trials Presumed asymptomatic carrier transmission of COVID-19 Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Asymptomatic cases in a family cluster with SARS-CoV-2 infection Characteristics of household transmission of COVID-19 Household transmission of SARS-CoV-2 COVID-19 pandemic and children: A review Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study Efficiency of quarantine during an epidemic of severe acute respiratory syndrome Director-General's Opening Remarks at the Media Briefing on COVID-19 Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study WHO. Novel Coronavirus (2019-nCoV) situation reports Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis SARS-CoV-2 transmission from people without COVID-19 symptoms How to cite this article Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: a family cluster cohort study